Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $56.16M.
ENTERPRISE VALUE (EV)
$56.16M
RenovoRx, Inc.
Market Cap
$63.07M
Enterprise Value (EV)
$56.16M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| RenovoRx, Inc. (RNXT) | $63.07M | $56.16M |
| Alps Group Inc (ALPS)vs › | $63.23M | N/A |
| Pliant Therapeutics, Inc. (PLRX)vs › | $62.85M | $66.71M |
| Heron Therapeutics, Inc. (HRTX)vs › | $63.41M | $191.04M |
| InterCure Ltd. (INCR)vs › | $63.64M | $106.49M |
| Fractyl Health, Inc. (GUTS)vs › | $61.67M | $75.27M |
| Gossamer Bio, Inc. (GOSS)vs › | $64.83M | $62.79M |
| Xilio Therapeutics, Inc. (XLO)vs › | $60.89M | N/A |
| Kalaris Therapeutics Inc (KLRS)vs › | $60.68M | $18.91M |
| XBiotech Inc. (XBIT)vs › | $65.85M | N/A |
Market Cap
$63.07M
Total Debt
$107000.00
Cash
$7.02M
Enterprise Value
$56.16M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
